key articles
Prognostic Factors for Renal Cell Carcinoma With Tumor Thrombus Extension
Thursday, 11 October 2007 - Renal cell carcinoma (RCC) patients with metastatic disease have poorer prognosis with a 5-year survival rate of less than 20% despite advances in surgical management and they have an immunotherapy...
Authors: Klatte et al.
Renal Function Outcomes in Patients Treated With Nephron Sparing Surgery for Bilateral Wilms Tumor
Wednesday, 10 October 2007 - Management of bilateral Wilms tumor represents a particular challenge in the consideration of long-term renal function for affected patients. Aggressive surgical resection to prevent recurrence...
Authors: Giel et al.
Case Report: Retroperitoneoscopic Radical Nephrectomy for Renal-Cell Carcinoma during Twin Pregnancy
Sunday, 7 October 2007 - Renal-cell carcinoma (RCC) is rarely reported during pregnancy. Both the open and the laparoscopic approach to nephrectomy have been used effectively and safely in pregnant patients with RCC. Stroup et...
Authors: Stroup et al.
Nephron-Sparing Surgery and Percutaneous Biopsies in Renal-Cell Carcinoma: A Global Impression among Endourologists
Saturday, 6 October 2007 - Nephron-sparing surgery (NSS) in small renal tumors is a safe and effective alternative to radical nephrectomy. However, the role of preoperative percutaneous needle biopsies (PNB) remains...
Authors: Kummerlin et al.
Immune suppression in renal cell carcinoma
Thursday, 20 September 2007 - The clear evidence that tumor-infiltrating lymphocytes with anti-tumor activity exist in situ raises the question why renal cell carcinomas (RCCs) progress in vivo. A complex array of factors and...
Authors: Frankenberger et al.
Intravenous urography for diagnosing synchronous upper-tract tumours in patients with newly diagnosed bladder carcinoma can be restricted to patients with high-risk superficial disease
Wednesday, 19 September 2007 - Bajaj et al. (2007) determined the incidence of synchronous upper-tract transitional cell carcinomas (TCCs) in patients with newly diagnosed bladder cancer and to evaluate the need for performing...
Authors: Bajaj et al.
Combination of radiofrequency ablation with antiangiogenic therapy for tumor ablation efficacy: study in mice
Saturday, 15 September 2007 - Hakime et al. (2007) prospectively determined whether modulation of renal cell carcinoma (RCC) tumor microvasculature by using the antiangiogenic drug sorafenib could increase the extent of...
Authors: Hakime et al.
Temsirolimus, Interferon Alfa or both for advanced renal-cell carcinoma
Monday, 10 September 2007 Authors: Hudes G, Carducci M, Tomczak P, Dutcher J, Figlin R, Kapoor A, Staroslawska E, Sosman J, McDermott D, Bodrogi I, Kovacevic Z, Lesovoy V, Schmidt-Wolf IG, Barbarash O, Gokmen E, O'Toole T,...
By: Mr Philip A. Cornford, Prof.Dr.Med. Oliver Hakenberg & Prof. A. Bjartell
Erythropoietin gene expression in renal carcinoma is considerably more frequent than paraneoplastic polycythemia
Sunday, 9 September 2007 - Signalling by erythropoietin (EPO) is increasingly recognised as a relevant mechanism in tumour biology, potentially leading to enhanced proliferation, angiogenesis and therapy resistance....
Authors: Wiesener et al.
C-reactive protein is an informative predictor of renal cell carcinoma-specific mortality: a European study of 313 patients
Monday, 3 September 2007 - Recent studies show a remarkable association between systemic inflammatory response to tumor proliferation and renal cell carcinoma-specific mortality (RCC-SM). Markers of inflammation, such as...
Authors: Karakiewicz et al.
